Health4 months ago
First Patient With PDAC Receives ELI-002 7P in Phase 2 AMPLIFY-7p Study
Christopher Haqq, MD, PhD About the Phase 2 AMPLIFY-7p Study Trial Name: First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects...
Recent Comments